Lipid composition heatmap for Study ST003657

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Sample source:U251 | Condition:anti-GLS1 siRNA | Method of exposure:Transfection
Sample source:U251 | Condition:Control | Method of exposure:Direct exposure
Sample source:U251 | Condition:Control | Method of exposure:Transfection
Sample source:U251 | Condition:Control | Method of exposure:Transwell b.End3
Sample source:U251 | Condition:Control | Method of exposure:Transwell b.End3 + iNHA
Sample source:U251 | Condition:Lipofectamine | Method of exposure:Transfection
Sample source:U251 | Condition:PUREG4-LA12-anti-GLS1 siRNA | Method of exposure:Direct exposure
Sample source:U251 | Condition:PUREG4-LA12-anti-GLS1 siRNA | Method of exposure:Transwell b.End3
Sample source:U251 | Condition:PUREG4-LA12-anti-GLS1 siRNA | Method of exposure:Transwell b.End3 + iNHA
Sample source:U251 | Condition:PUREG4-LA12 | Method of exposure:Direct exposure
Sample source:U251 | Condition:PUREG4-LA12 | Method of exposure:Transwell b.End3
Sample source:U251 | Condition:PUREG4-LA12 | Method of exposure:Transwell b.End3 + iNHA
Sample source:U-87MG | Condition:anti-GLS1 siRNA | Method of exposure:Transfection
Sample source:U-87MG | Condition:Control | Method of exposure:Direct exposure
Sample source:U-87MG | Condition:Control | Method of exposure:Transfection
Sample source:U-87MG | Condition:Control | Method of exposure:Transwell b.End3
Sample source:U-87MG | Condition:Control | Method of exposure:Transwell b.End3 + iNHA
Sample source:U-87MG | Condition:Lipofectamine | Method of exposure:Transfection
Sample source:U-87MG | Condition:PUREG4-LA12-anti-GLS1 siRNA | Method of exposure:Direct exposure
Sample source:U-87MG | Condition:PUREG4-LA12-anti-GLS1 siRNA | Method of exposure:Transwell b.End3
Sample source:U-87MG | Condition:PUREG4-LA12-anti-GLS1 siRNA | Method of exposure:Transwell b.End3 + iNHA
Sample source:U-87MG | Condition:PUREG4-LA12 | Method of exposure:Direct exposure
Sample source:U-87MG | Condition:PUREG4-LA12 | Method of exposure:Transwell b.End3
Sample source:U-87MG | Condition:PUREG4-LA12 | Method of exposure:Transwell b.End3 + iNHA
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Saturated FA1
  logo